Projekte

Ihr Ansprechpartner
Dr. Thomas Joos

Stellvertretender Institutsleiter

Tel: 07121 51530-844
E-Mail

EARLY DETECTION OF ADVERSE EFFECTS OF IMMUNOTHERAPEUTIC DRUG SUBSTANCES

COMPLEX HUMAN ORGANOTYPIC CO-CULTURE SYSTEMS COMBINED WITH SYSTEMS BIOLOGY BASED PATHWAY ANALYSIS - HuCoCSys

Projektname: HuCoCSys
EARLY DETECTION OF ADVERSE EFFECTS OF IMMUNOTHERAPEUTIC DRUG SUBSTANCES USING INNOVATIVE HIGHLY COMPLEX HUMAN ORGANOTYPIC CO-CULTURE SYSTEMS COMBINED WITH SYSTEMS BIOLOGY BASED PATHWAY ANALYSIS
Projektleiter: Dr. Thomas Joos, Dr. Nicole Schneiderhan, NMI (Koordinator: Dr. Manfred Schmolz)
Geldgeber: BMBF
Projektträger: PTJ
FKZ: 01GG717
Laufzeit von: 01.02.2008
Laufzeit bis: 31.12.2011

EARLY DETECTION OF ADVERSE EFFECTS OF IMMUNOTHERAPEUTIC DRUG SUBSTANCES USING INNOVATIVE HIGHLY COMPLEX HUMAN ORGANOTYPIC CO-CULTURE SYSTEMS COMBINED WITH SYSTEMS BIOLOGY BASED PATHWAY ANALYSIS - HuCoCSys

Beschreibung

Projektpartner

  • EDI GMBH
  • InterMed Discovery GmbH
  • MERCK KgGA
  • NMI Natural and Medical Sciences Institute at the University of Tübingen
  • University Hospital Ulm, Experimental Anaesthesiology

zurück